Morocco Parenteral Nutrition Market – Industry Trends and Forecast to 2031

Morocco Parenteral Nutrition Market Analysis and Size

Parenteral nutrition products features such as increasing need for novel, and advanced products will impact in launching new product by the manufactures into the market, which enhance its demand as well as cost effectiveness of parenteral nutrition market growth. Currently, various research studies are taking place, which is expected to create a competitive advantage for manufacturers to develop new and innovative drugs, which is expected to provide various other opportunities in the parenteral nutrition market. However, lack of awareness about malnutrition and rise in preference for eternal nutrition are expected to restraint the market growth in the forecast period.

Data Bridge Market Research analyzes that the Morocco parenteral nutrition market which was USD 6.8 billion in 2023, is likely to reach USD 10.5 million by 2031, and is expected to undergo a CAGR of 3.3% during the forecast period. “Trace elements” dominate the nutrient composites segment of the the market is growing due to the increasing novel and advanced products. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Morocco Parenteral Nutrition Market Scope and Segmentation

Market Definition

Parenteral nutrition refers to the administration of nutrition directly into the bloodstream, bypassing the digestive system. This method is used when a person's gastrointestinal tract is unable to properly absorb nutrients from food or when oral or enteral (tube feeding) intake is not feasible or insufficient to meet the body's nutritional needs.

Morocco Parenteral Nutrition Market Dynamics

Drivers

• Rising prevalence of chronic diseases

The rise in chronic diseases that affect the digestive system or impair nutrient absorption, such as Crohn's disease or certain types of cancer, might necessitate the use of parenteral nutrition.

• Increasing geriatric population

As the population ages, there may be an increase in conditions that necessitate parenteral nutrition, such as malabsorption syndromes or elderly individuals unable to eat or absorb nutrients orally.

Opportunities

• Rising advancements in healthcare infrastructure

Improved healthcare facilities and infrastructure in Morocco could lead to increased access to specialized medical treatments like parenteral nutrition.

• Increasing cases of premature births

Parenteral nutrition is often used in neonatal intensive care units to provide essential nutrients to premature babies or infants with gastrointestinal issues.

Restraints

• Regulatory approvals and compliance

Compliance with stringent regulatory standards and ensuring the quality and safety of parenteral nutrition solutions might pose challenges for manufacturers and healthcare providers.

• Accessibility and affordability

Access to specialized medical treatments, including parenteral nutrition, might be limited in certain regions, and the cost could be prohibitive for some patients, impacting their ability to receive this treatment.

Challenge

• Safety concerns

Potential risks associated with the use of parenteral nutrition, such as infection, metabolic imbalances, or complications related to intravenous access, could influence healthcare providers' and patients' decision.

This parenteral nutrition market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the parenteral nutrition market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In September 2020, Baxter had announced the U.S. F.D.A approval of Clinimix and Clinimix E for Patients Requiring Parenteral Nutrition. The novel clinimix formulations contain up to 80 g/L of amino acids, the highest protein in any multi-chamber bag available in the U.S. The approval received would provide timely treatment of individuals and would be submitted for post-market approval
• In February 2020, Fresenius Kabi Ag had announced that the Journal of Parenteral and Enteral Nutrition (JPEN) had published the Lipids in Parenteral Nutrition: Translating Guidelines into Clinical Practice”. The publication provides guidance on the use of fish oil-containing lipid emulsions in clinical practice. The ipublication had created awareness about the use of lipid emulsions in parenteral nutrition. It had formed partnerships with market players for the supply of lipid emulsion parenteral administration

Morocco Parenteral Nutrition Market Scope

The parenteral nutrition market is segmented the based on the basis of nutrient composition, delivery route, dosage form, patient type, indications, end-user, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Trace Elements
• Vitamins
• Minerals
• Single Dose Amino Acids
• Carbohydrates
• Lipid Emulsions

Delivery route                                                                    

• Total Parenteral Nutrition
• Peripheral Parenteral Nutrition

Dosage form

• Bags
• Bottles
• Vials
• Ampules

Patient type

• Infants/Children
• Adults

Indications

• Cancer Treatment
• Gastrointestinal Disorders
• Malnutrition
• Others

End User

• Hospitals
• Clinics
• Others

Distribution Channel

• Retail Sales
• Others

Healthcare Infrastructure growth Installed base and New Technology Penetration

The parenteral nutrition market also provides you with detailed market analysis for every country growth in nutrient deficiency treatment industry with parenteral nutrition product sales, the impact of advancement in the nutrient deficiency treatment products, products manufacturing, and distribution, and changes in regulatory scenarios with their support for the parenteral nutrition market. The data is available for historic period 2010-2021.

Competitive Landscape and Morocco Parenteral Nutrition Market Share Analysis

The parenteral nutrition market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width, and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to parenteral nutrition market.

Some of the major players operating in the parenteral nutrition market are:

• Baxter (U.S.)
• Fresenius Kabi AG (Germany)
• Otsuka Holdings Co., Ltd (Japan)
• Pfizer Inc. (U.S.)
• Hikma Pharmaceuticals PLC (U.K.)
• VIFOR PHARMA MANAGEMENT LTD. (Switzerland)

SKU-66398